LIVECAST Markets Briefs Calendar Search

Research

AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar Search AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive Account

Live News REGULATION FLASH L impact Sep 26, 2026, 12:25 AM UTC

OpenAI: models accessed publicly available info on SEC.gov and Investor.gov

SquawkNews Newsroom

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

OpenAI's models accessed public US Census, SEC data, Bloomberg News reports OpenAI's models accessed publicly available information from US government websites, including those of the Census Bureau and the Securities and Exchange Commission, Bloomberg News L impact | REGULATION | Sep 26, 2026, 12:28 AM UTC OpenAI’s models accessed public US census, SEC information L impact | REGULATION | Sep 26, 2026, 12:14 AM UTC Mirum Pharmaceuticals, Inc. (MIRM) Wins FDA Nod for Atebrioz in FOP The FDA approved Atebrioz (zilurgisertib) tablets to reduce total new heterotopic ossification in FOP patients aged 12+, licensed by Incyte to Mirum. A Rare Pediatric Disease PRV w L impact | REGULATION | Sep 25, 2026, 11:01 PM UTC Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz™ (zilurgisertib) tablets t L impact | REGULATION | Sep 25, 2026, 11:00 PM UTC US lawmakers seek to bar Chinese data center components in sensitive systems A bipartisan group introduced legislation to block Chinese-made optical transceivers from sensitive federal systems. The bill would give the government five years to comply and cou M impact | REGULATION | Sep 25, 2026, 10:35 PM UTC US FDA approves AbbVie drug for Parkinson's disease in adults The health regulator's website showed the approval on Friday. M impact | REGULATION | Sep 25, 2026, 10:10 PM UTC

SQUAWK/NEWS

Live financial news for traders. Read the headline on screen or hear it through LiveCast while you stay on the trade.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

Product

Open LiveCast
Plans & Pricing
Institutional API
How LiveCast Works
Live Markets
Session Briefs
RSS Feed
Calendar
Search
Instrument directory

Research

Macro
Politics
Prediction Markets
AI Market Assistant
News Archive

For Traders

Market Movers
US Stocks
Why News Moves Markets
News for Traders
How to Trade the News
What Is an Audio Squawk?
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.